Protective effect of edaravone against the ototoxicity of Pseudomonas aeruginosa exotoxin A

Acta Oto-Laryngologica

Volumn 126, Issue 1, 2006, Pages 15-19

  Takumida, Masaya ^a   Anniko, Matti ^b  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Auditory brainstem response; Edaravone; Hearing loss; Pseudomonas aeruginosa exotoxin A

Indexed keywords

NORPHENAZONE; PSEUDOMONAS EXOTOXIN; PSEUDOMONAS EXOTOXIN A; SCAVENGER; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ALBINISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDITORY THRESHOLD; COCHLEA FENESTRA; CONTROLLED STUDY; DRUG EFFECT; DRUG INSTILLATION; DRUG SPECIFICITY; EAR PROTECTION; EARDRUM; ECOLOGICAL NICHE; EVOKED BRAIN STEM AUDITORY RESPONSE; EXPOSURE; FREQUENCY ANALYSIS; HEARING LOSS; INJECTION; MALE; MIDDLE EAR; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RAT;

ADP RIBOSE TRANSFERASES; ANIMALS; ANTIPYRINE; AUDIOMETRY, EVOKED RESPONSE; AUDITORY THRESHOLD; BACTERIAL TOXINS; EAR, MIDDLE; EXOTOXINS; FREE RADICAL SCAVENGERS; HEARING LOSS, SENSORINEURAL; INJECTIONS, INTRAVENOUS; MALE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; TYMPANIC MEMBRANE; VIRULENCE FACTORS;

EID: 28844486753     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016480510038563     Document Type: Article

References (23)

1. Paparella MM, Morizono T, Le CT, Mancini F, Sipilä P, Choo YB, et al. Sensorineural hearing loss in otitis media. Ann Otol Rhinol Laryngol 1984;93:623-9.
2. Erkan M, Aslan T, Sevuku E, Guney E. Bacteriology of chronic suppurative otitis media. Ann Otol Rhinol Laryngol 1994;103:771-4.
3. Ogaard AR, Cryz S Jr, Berdal BP. Exotoxin A from various Pseudomonas aeruginosa cultures: in vivo activity measured by enzyme-linked immunosorbent assay (ELISA). Acta Pathol Microbiol Immunol Scand 1985;93:217-23.
4. Pollack M. Special role of Pseudomonas aeruginosa in chronic suppurative otitis media. Ann Otol Rhinol Laryngol Suppl 1988;131:10-3.
5. Lundman L, Santi PA, Morizono T, Harada T, Juhn SK, Bagger- Sjöbäck D. Inner ear damage and passage through the round window membrane of Pseudomonas aeruginosa Exotoxin A in a chinchilla model. Ann Otol Rhinol Laryngol 1992;101:437-44.
6. Stenqvist M, Anniko M, Pettersson Å. Effect of Pseudomonas aeruginosa Exotoxin A on inner ear function. Acta Otolaryngol (Stockh) 1997;117:73-9.
7. Amaee FR, Comis SD, Osborne MP. NG-Methyl-L-arginine protects the guinea pig cochlea from the cytotoxic effects of pneumolysine. Acta Otolaryngol (Stockh) 1995;115:386-91
8. Takumida M, Anniko M, Popa R. Possible involvement of free radicals in lipopolysaccharide-induced labyrinthitis in the guinea pig: a morphological and functional investigation. ORL J Otorhinolaryngol Relat Spec 1998;60:246-53.
9. Takumida M, Anniko M, Popa R. Lipopolysaccharide-induced expression of inducible nitric oxide synthase in the guinea pig organ of Corti. Hear Res 2000;140:91-8.
10. Popa R, Anniko M, Takumida M. Otoprotectant minimizes hearing defects caused by Pseudomonas aeruginosa exotoxin A. Acta Otolaryngol 2000;120:350-8.
11. Takumida M, Anniko M, Popa R, Zhang DM. Pharmacological models for inner ear therapy with emphasis on nitric oxide. Acta Otolaryngol 2001;121:16-20.
12. Takumida M, Anniko M. Nitric oxide in the inner ear. Curr Opin Neurol 2002;15:11-5.
13. Kaygusuz I, Ozturk A, Ustundag B, Yalcin S. Role of free oxygen radicals in noise-related hearing impairment. Hear Res 2001;162:43-7.
14. Yamasoba T, Schacht J, Shoji F, Miller JM. Attenuation of cochlear damage from noise trauma by an iron chelator, a free radical scavenger and glial cell line-derived neurotrophic factor in vivo. Brain Res 1999;815:317-25.
15. Sha S-H, Schacht J. Antioxidants attenuate gentamicin-induced free-radical formation in vitro and ototoxicity in vivo: D-methionine is a potent protectant. Hear Res 2000;142:34-40.
16. Tabuchi K, Tsuji S, Ito Z, Hara A, Kusakari J. Does xanthine oxidase contribute to the hydroxyl radical generation in ischemia and reperfusion of the cochlea? Hear Res 2001;153:1-6.
17. Yamamoto T, Yuki S, Watanabe T, Mitsuka M, Saito K, Kogure K. Delayed neuronal death prevented by inhibition of increased hydroxyradical formation in a transient cerebral ischemia. Brain Res 1997;762:240-2.
18. Edaravone Acute Infarction Study Group. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters. Cerebrovasc Dis 2003;15:222-9.
19. Watanabe T, Morita I, Nishi H, Murota S. Preventive effect of MCI-186 on 15-HPETE induced vascular endothelial injury in vitro. Prostaglandins. Leukot Essent Fatty Acids 1998;33:81-7.
20. Takemoto T, Sugahara K, Okuda T, Shimogori H, Yamashita H. The clinical free radical scavenger, edaravone, protects cochlear hair cells from acoustic trauma. Eur J Pharmacol 2004;487:113-6.
21. Horiike O, Shimogori H, Ikeda T, Yamashita H. Protective effect of edaravone against streptomycin-induced vestibulotoxicity in the guinea pig. Eur J Pharmacol 2003;464:75-8.
22. Horiike O, Shimogori H, Yamashita H. Effect of edaravone on streptomycin-induced vestibulotoxicity in the guinea pig. Laryngoscope 2004;114:1630-2.
23. Maetani T, Hakuba N, Taniguchi M, Hyodo J, Shimizu Y, Gyo K. Free radical scavenger protects against inner hair cell loss after cochlear ischemia. Neuroreport 2003;14:1881-4.